GlycoVaxyn AG is a company that provides Recombinant DNA, Conjugate vaccine, Glycoprotein and more. GlycoVaxyn AG is headquartered in Switzerland ZURICH. GlycoVaxyn AG was founded in 2004. GlycoVaxyn AG has a total of 82 patents
Northeast Agricultural UniversityGenetics Institute LLCBIONEER Corp.Hexal AGGennova Biopharmaceuticals Ltd.Amgen Canada, Inc.Seevix Material Sciences Ltd.Pasteur Institute of Iran
Mitsubishi Tanabe Pharma Corp.Forschungszentrum Jülich GmbHFourth Military Medical UniversityFourth Military Medical UniversityThe General Hospital Of The People'S Liberation ArmyChinese People's Liberation Army General HospitalThe Medical Research CouncilLudwig Institute for Cancer Research Ltd.The University of SouthamptonOncoTherapy Science, Inc.Bayer Animal Health GmbHCSL Ltd.Third Military Medical UniversityThird Military Medical UniversityBavarian Nordic A/SUniversity of CopenhagenMcMaster UniversityPanacea Biotec Ltd.Green Cross Co., Ltd.Capital Medical UniversityTrudell Medical InternationalUniversity of GroningenAgResearch Ltd.Novavax, Inc.Ospedale San Raffaele SrlUniversity of ZaragozaFundação Oswaldo CruzSerum Institute of India Pvt Ltd.Il-Yang Pharmaceutical Co., Ltd.Dynavax Technologies Corp.